Anti-sepsis protection of Xuebijing injection is mediated by differential regulation of pro- and anti-inflammatory Th17 and T regulatory cells in a murine model of polymicrobial sepsis
Authors:
- 1 January 2018
- journal article
- research article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 211, 358-365
Abstract
No abstract availableKeywords
Funding Information
- National Key Basic Research Program of China (2012CB723504)
- National Major New Drug Discovery (2013ZX0920102)
- National Science Foundation of China (81274128)
This publication has 42 references indexed in Scilit:
- Immunization withStaphylococcus aureusiron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis modelHuman Vaccines & Immunotherapeutics, 2012
- The evolving experience with therapeutic TNF inhibition in sepsis: considering the potential influence of risk of deathExpert Opinion on Investigational Drugs, 2011
- Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1Cell, 2011
- Identification of the major constituents in Xuebijing injection by HPLC‐ESI‐MSPhytochemical Analysis, 2011
- Characterization and Modulation of the Immunosuppressive Phase of SepsisInfection and Immunity, 2010
- Immunodesign of experimental sepsis by cecal ligation and punctureNature Protocols, 2008
- Advances in understanding sepsisEuropean Journal of Anaesthesiology, 2008
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006
- Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic CellsScience, 2003
- Control of Regulatory T Cell Development by the Transcription Factor Foxp3Science, 2003